alpha tryptasemia

  1. SNT Gatchaman

    Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders, 2025, Stino et al.

    Autonomic function testing and symptom severity in patients with suspected mast cell activation disorders We assessed both objective and subjective measures of autonomic severity in patients with formally classified mast cell activation disorder (MCAD), hereditary alpha tryptasemia (HaT), and...
  2. Yann04

    Review Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine, 2020, Valent et al

    Abstract: Mast cell activation (MCA) is seen in a variety of clinical contexts and pathologies, including IgE-dependent allergic inflammation, other immunologic and inflammatory reactions, primary mast cell (MC) disorders, and hereditary alpha tryptasemia (HAT). MCA-related symptoms range from...
Back
Top Bottom